Christopher B. Ehrlich

Insider Reports History

Entity
Individual
Location
499 Illinois Street, Suite 200, San Francisco, CA
Signature
/s/ Christopher B. Ehrlich
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Christopher B. Ehrlich:

Stock Role Class Num Shares Value Price $ Report Date Ownership
CERO THERAPEUTICS HOLDINGS, INC. Chairman and CEO, Director Common Stock 5.79M $579K $0.10 Sep 25, 2024 Direct
CERO THERAPEUTICS HOLDINGS, INC. Chairman and CEO, Director Common Stock 3.6K $360 $0.10 Sep 25, 2024 By Spouse
CERO THERAPEUTICS HOLDINGS, INC. Chairman and CEO, Director Series A Convertible Preferred Stock 0 $0 $1,000.00 Sep 25, 2024 Direct
CERO THERAPEUTICS HOLDINGS, INC. Chairman and CEO, Director Stock Option (Right to Buy) 1.28M Dec 2, 2024 Direct
PHOENIX BIOTECH ACQUISITION CORP. Chairman and CEO, Director Warrants 5K Feb 14, 2024 Direct
eFFECTOR Therapeutics, Inc. Director Stock Option (Right to Buy) 800 Jun 13, 2024 Direct
PHOENIX BIOTECH ACQUISITION CORP. Chairman and CEO, Director Convertible Promissory Note 0 Feb 14, 2024 By Phoenix Biotech Sponsor, LLC
PHOENIX BIOTECH ACQUISITION CORP. Chairman and CEO, Director Warrants 0 Feb 14, 2024 By Phoenix Biotech Sponsor, LLC

Insider Reports Filed by Christopher B. Ehrlich

Symbol Company Period Transactions Value $ Form Type Date Filed Role
CERO CERO THERAPEUTICS HOLDINGS, INC. Dec 2, 2024 1 $0 4 Dec 4, 2024 Chairman and CEO, Director
CERO CERO THERAPEUTICS HOLDINGS, INC. Sep 25, 2024 3 -$275K 4 Oct 2, 2024 Interim Chairman and CEO, Director
LPAA Launch One Acquisition Corp. Jul 11, 2024 0 $0 3 Jul 11, 2024 Chief Executive Officer, Director
EFTR eFFECTOR Therapeutics, Inc. Jun 13, 2024 1 $0 4 Jun 13, 2024 Director
CERO CERO THERAPEUTICS HOLDINGS, INC. Mar 25, 2024 1 $0 4 Mar 27, 2024 Director
EFTR eFFECTOR Therapeutics, Inc. Feb 19, 2024 1 $0 4 Feb 21, 2024 Director
CERO PHOENIX BIOTECH ACQUISITION CORP. Feb 14, 2024 11 $275K 4 Feb 16, 2024 Director
EFTR eFFECTOR Therapeutics, Inc. Jun 22, 2023 1 $0 4 Jun 22, 2023 Director
EFTR eFFECTOR Therapeutics, Inc. Jan 20, 2023 1 $0 4 Jan 24, 2023 Director
EFTR eFFECTOR Therapeutics, Inc. Oct 4, 2022 1 $197 4 Oct 6, 2022 Director
EFTR eFFECTOR Therapeutics, Inc. Sep 26, 2022 1 $10.4K 4 Sep 27, 2022 Director
EFTR eFFECTOR Therapeutics, Inc. Jun 9, 2022 1 $0 4 Jun 13, 2022 Director
EFTR eFFECTOR Therapeutics, Inc. Feb 14, 2022 2 $13.2K 4 Feb 22, 2022 Director
EFTR eFFECTOR Therapeutics, Inc. Feb 8, 2022 2 $9.67K 4 Feb 10, 2022 Director
EFTR eFFECTOR Therapeutics, Inc. Feb 3, 2022 2 $30.8K 4 Feb 7, 2022 Director
EFTR eFFECTOR Therapeutics, Inc. Jan 27, 2022 1 $26.5K 4 Jan 31, 2022 Director
PBAX PHOENIX BIOTECH ACQUISITION CORP. Oct 8, 2021 3 $367K 4 Oct 12, 2021 CEO and Secretary, Director, 10%+ Owner
EFTR eFFECTOR Therapeutics, Inc. Oct 6, 2021 1 $0 4 Oct 8, 2021 Director
PBAX PHOENIX BIOTECH ACQUISITION CORP. Oct 5, 2021 0 $0 3 Oct 5, 2021 CEO and and Secretary, Director, 10%+ Owner
EFTR eFFECTOR Therapeutics, Inc. Aug 25, 2021 6 $0 4 Aug 27, 2021 Director